Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Thyrocare Technologies Ltd ( (IN:THYROCARE) ) has issued an update.
Thyrocare Technologies Limited has appointed senior healthcare and diagnostics professional Mr. Rajdeep Panwar as Chief Commercial Officer, categorised as Senior Management Personnel, with effect from 5 January 2026, following approval by the Board of Directors based on the Nomination and Remuneration Committee’s recommendation. With over 21 years of experience leading large diagnostic networks and commercial functions at organisations including Medanta Labs, Apollo Diagnostics and Dr. Lal PathLabs, Panwar’s mandate is expected to strengthen Thyrocare’s commercial strategy, network expansion and operational scaling across diverse markets, reinforcing its competitive position in India’s diagnostics sector.
More about Thyrocare Technologies Ltd
Thyrocare Technologies Limited is an Indian diagnostic and preventive healthcare services company, operating a network of laboratories and collection centres that provide pathology and diagnostic testing across metro and non-metro markets. The company focuses on high-volume, standardized testing and has positioned itself as a key player in the organised diagnostics industry in India, serving hospitals, clinics and retail consumers through a hub-and-spoke model.
Average Trading Volume: 96,904
Technical Sentiment Signal: Strong Buy
Current Market Cap: 73.07B INR
For an in-depth examination of THYROCARE stock, go to TipRanks’ Overview page.